| Name | No. | For Patients with | Purpose |
|---|---|---|---|
| Spine SABR | 20-03 | oligometastatic disease (OMD) or oligoprogressive disease (OPD) solid tumour spine metastases |
The Spine SABR (CTRIAL-IE 20-03) study has been designed to determine the maximum tolerated dose of stereotactic radiotherapy, to the spine, delivered in two fractions with a simultaneous integrated boost technique, for patients with oligometastatic or oligoprogressive spine disease. |
DSSG Group: Central Nervous System
Serum Protein Markers for Glioma
| Name | No. | For Patients with | Purpose |
|---|---|---|---|
| Serum Protein Markers for Glioma | 08-13 | Brain cancer (glioma). |
The purpose of this trials is to investigate proteins and genes in brain tumours. |